# Arvinas, Inc.: filings

ARVN · Nasdaq · CIK 1655759 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/arvn.md) · [Financials](/companies/arvn/financials.md) · [Filings](/companies/arvn/filings.md) · [Insiders](/companies/arvn/insiders.md)

## Reports and events: 159 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 243, 8-K 114, 3 36, 144 29, SC 13G/A 28, 10-Q 24, SC 13G 16, S-8 13, DEFA14A 9, 10-K 8, DEF 14A 8, CORRESP 7, SCHEDULE 13G/A 7, 424B5 6, UPLOAD 6, ARS 4, CT ORDER 4, 4/A 3, D 3, EFFECT 3, S-3ASR 3, SCHEDULE 13G 3, 424B3 2, S-3 2, SCHEDULE 13D/A 2, 3/A 1, 424B4 1, 5 1, 8-A12B 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, S-1 1, S-1/A 1, S-1MEF 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-04 | 16:08 ET | [10-Q](/filings/0001628280-26-052554.md) | Quarterly report, period 2026-06-30 | 0001628280-26-052554 |
| 2026-08-04 | 07:02 ET | [8-K](/filings/0001628280-26-052139.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-052139 |
| 2026-06-25 | 16:18 ET | [8-K](/filings/0001628280-26-045520.md) | 5.07 Shareholder vote results | 0001628280-26-045520 |
| 2026-06-22 | 16:10 ET | [8-K](/filings/0001628280-26-044627.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-044627 |
| 2026-06-16 | 16:30 ET | [8-K](/filings/0001628280-26-043559.md) | 8.01 Other events | 0001628280-26-043559 |
| 2026-06-02 | 16:39 ET | [8-K](/filings/0001628280-26-039818.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-039818 |
| 2026-05-12 | 07:15 ET | [8-K](/filings/0001628280-26-033875.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-033875 |
| 2026-05-12 | 07:14 ET | [8-K](/filings/0001628280-26-033874.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-033874 |
| 2026-05-11 | 17:18 ET | [10-Q](/filings/0001628280-26-033669.md) | Quarterly report, period 2026-03-31 | 0001628280-26-033669 |
| 2026-05-01 | 12:58 ET | [8-K](/filings/0001628280-26-029210.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-029210 |
| 2026-04-29 | 09:23 ET | [DEF 14A](/filings/0001628280-26-028156.md) | Proxy statement, period 2026-06-24 | 0001628280-26-028156 |
| 2026-03-18 | 07:06 ET | [8-K](/filings/0001628280-26-019026.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-019026 |
| 2026-02-24 | 17:18 ET | [10-K](/filings/0001628280-26-011226.md) | Annual report, period 2025-12-31 | 0001628280-26-011226 |
| 2026-02-24 | 07:02 ET | [8-K](/filings/0001628280-26-010865.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-010865 |
| 2026-02-12 | 07:06 ET | [8-K](/filings/0001628280-26-007463.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-007463 |
| 2025-12-08 | 06:36 ET | [8-K](/filings/0001628280-25-055682.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-055682 |
| 2025-11-05 | 16:06 ET | [10-Q](/filings/0001628280-25-049527.md) | Quarterly report, period 2025-09-30 | 0001628280-25-049527 |
| 2025-11-05 | 07:02 ET | [8-K](/filings/0001628280-25-049235.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-049235 |
| 2025-10-24 | 16:02 ET | [8-K](/filings/0001628280-25-046259.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-046259 |
| 2025-10-20 | 06:06 ET | [8-K](/filings/0001628280-25-045445.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-045445 |
| 2025-10-15 | 17:18 ET | [SCHEDULE 13D/A](/filings/0000935836-25-000639.md) | Ownership report, active investor, amended | 0000935836-25-000639 |
| 2025-10-06 | 07:37 ET | [8-K](/filings/0001628280-25-044212.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-044212 |
| 2025-09-17 | 16:32 ET | [8-K](/filings/0001655759-25-000147.md) | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001655759-25-000147 |
| 2025-08-22 | 16:44 ET | [SCHEDULE 13D/A](/filings/0000935836-25-000557.md) | Ownership report, active investor, amended | 0000935836-25-000557 |
| 2025-08-08 | 16:13 ET | [8-K](/filings/0001655759-25-000141.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001655759-25-000141 |
| 2025-08-06 | 17:17 ET | [10-Q](/filings/0001655759-25-000139.md) | Quarterly report, period 2025-06-30 | 0001655759-25-000139 |
| 2025-08-06 | 07:03 ET | [8-K](/filings/0001655759-25-000136.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001655759-25-000136 |
| 2025-07-09 | 07:01 ET | [8-K](/filings/0001655759-25-000130.md) | 5.02 Departure or appointment of officers or directors | 0001655759-25-000130 |
| 2025-06-30 | 07:00 ET | [8-K](/filings/0001655759-25-000128.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001655759-25-000128 |
| 2025-06-16 | 18:10 ET | [SCHEDULE 13D](/filings/0000935836-25-000426.md) | Ownership report, active investor | 0000935836-25-000426 |
| 2025-06-13 | 07:12 ET | [8-K](/filings/0001655759-25-000103.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001655759-25-000103 |
| 2025-06-06 | 16:22 ET | [8-K](/filings/0001655759-25-000100.md) | 5.02 Departure or appointment of officers or directors | 0001655759-25-000100 |
| 2025-06-06 | 07:02 ET | [8-K](/filings/0001655759-25-000098.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001655759-25-000098 |
| 2025-06-02 | 06:12 ET | [8-K](/filings/0001655759-25-000095.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001655759-25-000095 |
| 2025-05-01 | 17:16 ET | [10-Q](/filings/0001655759-25-000085.md) | Quarterly report, period 2025-03-31 | 0001655759-25-000085 |
| 2025-05-01 | 07:05 ET | [8-K](/filings/0001655759-25-000081.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001655759-25-000081 |
| 2025-04-29 | 17:06 ET | [DEF 14A](/filings/0001655759-25-000075.md) | Proxy statement, period 2025-06-25 | 0001655759-25-000075 |
| 2025-04-28 | 07:32 ET | [8-K](/filings/0001655759-25-000069.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001655759-25-000069 |
| 2025-04-04 | 07:01 ET | [8-K](/filings/0001655759-25-000066.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001655759-25-000066 |
| 2025-03-11 | 06:48 ET | [8-K](/filings/0001655759-25-000057.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001655759-25-000057 |
| 2025-02-11 | 17:16 ET | [10-K](/filings/0001655759-25-000016.md) | Annual report, period 2024-12-31 | 0001655759-25-000016 |
| 2025-02-11 | 07:02 ET | [8-K](/filings/0001655759-25-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001655759-25-000008 |
| 2025-01-22 | 07:05 ET | [8-K](/filings/0001655759-25-000006.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement | 0001655759-25-000006 |
| 2025-01-10 | 08:50 ET | [8-K](/filings/0001655759-25-000004.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001655759-25-000004 |
| 2025-01-06 | 17:09 ET | [8-K](/filings/0001655759-25-000002.md) | 1.01 Entry into a material agreement | 0001655759-25-000002 |
| 2024-12-16 | 17:24 ET | [8-K](/filings/0001655759-24-000142.md) | 1.01 Entry into a material agreement | 0001655759-24-000142 |
| 2024-12-10 | 09:07 ET | [8-K](/filings/0001655759-24-000140.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001655759-24-000140 |
| 2024-11-19 | 17:46 ET | [8-K](/filings/0001655759-24-000137.md) | 8.01 Other events | 0001655759-24-000137 |
| 2024-10-30 | 17:01 ET | [10-Q](/filings/0001655759-24-000131.md) | Quarterly report, period 2024-09-30 | 0001655759-24-000131 |
| 2024-10-30 | 07:04 ET | [8-K](/filings/0001655759-24-000128.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001655759-24-000128 |

Page 1 of 4. [Older](/companies/arvn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.